Literature DB >> 10235155

Genetic testing in families with hereditary nonpolyposis colon cancer.

C Lerman1, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch, H T Lynch.   

Abstract

CONTEXT: Genetic testing for hereditary nonpolyposis colon cancer (HNPCC) is available, but the rates of acceptance of testing or barriers to participation are not known.
OBJECTIVE: To investigate rates and predictors of utilization of genetic testing for HNPCC.
DESIGN: Cohort study conducted between July 1996 and July 1998.
SETTING: Hereditary nonpolyposis colon cancer family registry. PARTICIPANTS: Adult male and female members (n = 208) of 4 extended HNPCC families contacted for a baseline telephone interview.
INTERVENTIONS: Family education and individual genetic counseling. MAIN OUTCOME MEASURE: Participant acceptance of HNPCC test results.
RESULTS: Of the 208 family members, 90 (43%) received test results and 118 (57%) declined. Of 139 subjects (67%) who completed a baseline telephone interview, 84 (60%) received test results and 55 (40%) declined. Of the 84 subjects who received test results, 35 (42%) received information indicating that they had HNPCC-associated mutations and 49 (58%) that they did not. Test acceptors had higher education levels (odds ratio [OR], 3.74; 95% confidence interval [CI], 2.49-5.61) and were more likely to have participated in a previous genetic linkage study (OR, 4.30; 95% CI, 1.84-10.10). The presence of depression symptoms significantly reduced rates of HNPCC test use (OR, 0.34; 95% CI, 0.17-0.66). Although rates of test use were identical among men and women, the presence of depression symptoms resulted in a 4-fold decrease in test use among women (OR, 0.25; 95% CI, 0.08-0.80) and a smaller, nonsignificant reduction among men (OR, 0.49; 95% CI, 0.19-1.27).
CONCLUSIONS: Despite having significantly elevated risks of developing colon cancer, a relatively small proportion of HNPCC family members are likely to use genetic testing. Barriers to test acceptance may include less formal education and the presence of depression symptoms, especially among women. Additional research is needed to generalize these findings to different clinical settings and racially diverse populations.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1999        PMID: 10235155     DOI: 10.1001/jama.281.17.1618

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  60 in total

1.  Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.

Authors:  K Aktan-Collan; J P Mecklin; A de la Chapelle; P Peltomäki; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

2.  Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.

Authors:  Trine Levin Bodd; Jon Reichelt; Ketil Heimdal; Pal Moller
Journal:  J Genet Couns       Date:  2003-10       Impact factor: 2.537

3.  The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience.

Authors:  Diana L Jones; Ellen W Clayton
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-15

4.  Genetic counseling for personal genomic testing: optimizing client uptake of post-test telephonic counseling services.

Authors:  Elissa Levin; Sara Riordan; Jana Klein; Shannon Kieran
Journal:  J Genet Couns       Date:  2012-04-28       Impact factor: 2.537

5.  Prenatal genetic testing: an investigation of determining factors affecting the decision-making process.

Authors:  Monica Pivetti; Giannino Melotti
Journal:  J Genet Couns       Date:  2012-04-03       Impact factor: 2.537

Review 6.  Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors:  Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal:  Curr Opin Mol Ther       Date:  2008-06

7.  Cascade genetic testing for mismatch repair gene mutations.

Authors:  R J Mitchell; R K Ferguson; A Macdonald; M G Dunlop; H Campbell; M E Porteous
Journal:  Fam Cancer       Date:  2008-04-04       Impact factor: 2.375

8.  Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Authors:  M J Esplen; N Stuckless; S Gallinger; M Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; J Green; K Butler; H V Petersen; J Wong
Journal:  Clin Genet       Date:  2011-10-03       Impact factor: 4.438

9.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

10.  The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.

Authors:  Anita Caruso; Cristina Vigna; Gabriella Maggi; Fabio Massimo Sega; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2008-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.